Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Genetic Polymorphisms on Ranibizumab Treatment Outcomes in Wet Age-Related Macular Degeneration (AMD)

NCT01676506 is registered in ClinicalTrials.gov with Russian Academy of Medical Sciences as lead sponsor.

NCT NCT01676506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01676506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Genetic Polymorphisms on Ranibizumab Treatment Outcomes in Wet Age-Related Macular Degeneration (AMD)
Lead sponsor
Russian Academy of Medical Sciences
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2011
Completion date
October 31, 2015
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration